Skip to main content

Advertisement

Log in

Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

In this clinical trial of 12.5 or 25 mg/day of hydrochlorothiazide, the urine calcium showed significant decreases from placebo in men at one year, but the effects had waned by 3 years. Serum bicarbonate was consistently greater in the thiazide than in the placebo groups throughout the three years. These effects could be beneficial to the skeleton.

Introduction

Previous studies have shown increased bone density and reduced risk of fracture in patients taking thiazide diuretics. The long-term effects of low-dose thiazides on mineral metabolism have not been reported in normal subjects.

Methods

We conducted a randomized, double-blinded trial in normals aged 60–79 years, using hydrochlorothiazide 12.5 or 25 mg/d or placebo for three years. Subjects were encouraged to maintain calcium intake of 1,000 to 1,500 mg/day. Measurements of serum and urine calcium metabolism were done at baseline, six months, and yearly. Data were analyzed in 88 men and 177 women who had taken study medication. Adjusted change in the measurements from baseline to one and three years were compared among groups.

Results

The calcium intake increased in all groups. Urine calcium per day was significantly lower in thiazide than placebo groups in men at one year but not at three years; in women the changes were not significantly different. Serum bicarbonate was higher in thiazide compared to placebo groups at one and three years. No changes were seen in serum calcium, phosphate, parathyroid hormone, sodium or magnesium.

Conclusions

The results suggest that both increased calcium availability from a hypocalciuric effect and reduction in acid-induced bone buffering could be mechanisms for the beneficial skeletal effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, Cornoni-Huntley J, Ostfeld AM (1990) Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322:286–290

    PubMed  CAS  Google Scholar 

  2. Jones G, Nguyen T, Sambrook PN, Eisman JA (1995) Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 10:106–111

    Article  PubMed  CAS  Google Scholar 

  3. Feskanich D, Willett WC, Stampfer MJ, Colditz GA (1997) A prospective study of thiazide use and fractures in women. Osteoporos Int 7:79–84

    Article  PubMed  CAS  Google Scholar 

  4. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. Jama 292:1326–1332

    Article  PubMed  CAS  Google Scholar 

  5. Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167–175

    Article  PubMed  CAS  Google Scholar 

  6. Wiens M, Etminan M, Gill SS, Takkouche B (2006) Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350–362

    Article  PubMed  CAS  Google Scholar 

  7. Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR (1993) Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118:657–665

    PubMed  CAS  Google Scholar 

  8. Orwoll ES, Bevan L, Phipps KR (2000) Determinants of bone mineral density in older men. Osteoporos Int 11:815–821

    Article  PubMed  CAS  Google Scholar 

  9. Transbol I, Christensen MS, Jensen GF, Christiansen C, McNair P (1982) Thiazide for the postponement of postmenopausal bone loss. Metabolism 31:383–386

    Article  PubMed  CAS  Google Scholar 

  10. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE (2000) Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133:516–526

    PubMed  CAS  Google Scholar 

  11. Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD (2000) Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 109:362–370

    Article  PubMed  CAS  Google Scholar 

  12. Wasnich RD, Davis JW, He YF, Petrovich H, Ross PD (1995) A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteoporos Int 5:247–251

    Article  PubMed  CAS  Google Scholar 

  13. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489

    Article  PubMed  CAS  Google Scholar 

  14. Kristal A, Feng Z, Coates R, Oberman A, George V (1997) Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am j Epidemiol 146:856–869

    PubMed  CAS  Google Scholar 

  15. Preminger GM, Pak CY (1987) Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria. J Urol 137:1104–1109

    PubMed  CAS  Google Scholar 

  16. Odvina CV, Preminger GM, Lindberg JS, Moe OW, Pak CY (2003) Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int 63:240–247

    Article  PubMed  CAS  Google Scholar 

  17. Greenberg A (2000) Diuretic complications. Am J Med Sci 319:10–24

    Article  PubMed  CAS  Google Scholar 

  18. Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA (1997) Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol 272:C109–116

    PubMed  CAS  Google Scholar 

  19. Lalande A, Roux C, Graulet AM, Schiavi P, De Vernejoul MC (1998) The diuretic indapamide increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium. J Bone Miner Res 13:1444–1450

    Article  PubMed  CAS  Google Scholar 

  20. Nicolet-Barousse L, Blanchard A, Roux C, Pietri L, Bloch-Faure M, Kolta S, Chappard C, Geoffroy V, Morieux C, Jeunemaitre X, Shull GE, Meneton P, Paillard M, Houillier P, De Vernejoul MC (2005) Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice. J Bone Miner Res 20:799–808

    Article  PubMed  CAS  Google Scholar 

  21. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z (2002) Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87:3248–3254

    Article  PubMed  CAS  Google Scholar 

  22. Sutton RA (1985) Diuretics and calcium metabolism. Am J Kidney Dis 5:4–9

    PubMed  CAS  Google Scholar 

  23. Bollard MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reed IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18:479–486

    Article  CAS  Google Scholar 

  24. Lemann J Jr, Bushinsky DA, Hamm LL (2003) Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 285:F811–832

    PubMed  CAS  Google Scholar 

  25. Bushinsky DA (2001) Acid-base imbalance and the skeleton. Eur J Nutr 40:238–244

    Article  PubMed  CAS  Google Scholar 

  26. Frassetto LA, Nash E, Morris RC, Sebastian A (2000) Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion. Kidney Int 58:748–752

    Article  PubMed  CAS  Google Scholar 

  27. Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R (2006) Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. J Am Soc Nephrol 17:3213–3222

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

National Institutes of Health (AG09825) and University of Washington Clinical Nutrition Research Unit, National Institutes of Health (P30 DK35816). The study medications were provided by Ciba-Geigy.

Conflicts of interest

None of the authors have any conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. M. Ott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ott, S.M., LaCroix, A.Z., Scholes, D. et al. Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. Osteoporos Int 19, 1315–1322 (2008). https://doi.org/10.1007/s00198-008-0612-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0612-4

Keywords

Navigation